Immulina 400 Tablet

Introduction

Immulina is a prescription medication that contains the active ingredient Pidotimod. It is available under the brand name Immulina. This medication is primarily used for its immunomodulatory properties, which help to enhance the body’s immune response.

Uses

Immulina is prescribed to treat various conditions related to the immune system, such as recurrent respiratory infections, including those affecting the upper respiratory tract (nose, throat, and sinuses). It is also used in the management of immunodeficiency disorders, which can lead to recurrent infections. The medication helps to strengthen the immune system and reduce the frequency and severity of infections.

Dosage and Administration

The dosage of Immulina may vary depending on the individual patient and the specific condition being treated. Follow the instructions provided by your healthcare professional. Typically, the recommended dosage for adults is one tablet taken twice daily. The tablets should be swallowed whole with a glass of water, preferably after meals. Take the medication regularly and at the same time each day to achieve the best results.

Mechanism of Action

The active ingredient in Immulina, Pidotimod, works by modulating the immune response in the body. It helps to stimulate the activity of certain immune cells, such as T-lymphocytes and natural killer cells, which play a crucial role in fighting off infections. By enhancing the immune system’s ability to recognize and respond to pathogens, Pidotimod helps to reduce the frequency and severity of infections, thereby improving overall health.

Side Effects

Common side effects may include mild gastrointestinal discomfort, such as nausea, vomiting, or diarrhea. These side effects are usually temporary and resolve on their own. However, if they persist or become more severe, consult your healthcare professional.

In rare cases, some individuals may experience serious allergic reactions to the medication. If you develop symptoms such as difficulty breathing, swelling of the face or throat, or a rash, seek immediate medical attention.

Drug Interactions

Immulina may interact with certain medications, supplements, or substances. Inform your healthcare professional about all the medications you are currently taking, including over-the-counter drugs and herbal supplements. Some medications, such as immunosuppressants or corticosteroids, may interact with Immulina and affect its effectiveness or increase the risk of side effects. Your healthcare professional will be able to advise you on any potential drug interactions and adjust your treatment plan accordingly.

Precautions

Before starting treatment with Immulina, inform your healthcare professional about any existing medical conditions or allergies you may have. This medication may not be suitable for individuals with certain conditions or those who are taking certain medications.

Immulina should not be used in individuals with a known hypersensitivity to Pidotimod or any of the other ingredients in the medication. Avoid using the medication during pregnancy or while breastfeeding, unless specifically advised by your healthcare professional.

Storage

Immulina should be stored in a cool, dry place away from direct sunlight and moisture. Keep it out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Immulina as prescribed by your healthcare professional. Do not exceed the recommended dosage.
• take the medication regularly and at the same time each day for optimal results.
• If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you have any questions or concerns about the medication, do not hesitate to consult your healthcare professional.
• Follow good hygiene practices, such as washing hands regularly and avoiding close contact with individuals who have active infections, to further reduce the risk of recurrent infections.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Pidotimod (International database) (Drugs.com) [Accessed 22 Jun. 2024] (online) Available at:
• Mahashur A, Thomas PK, Mehta P, Nivangune K, Muchhala S, Jain R. Pidotimod: In-depth review of current evidence. Lung India. 2019 Sep-Oct;36(5):422-433. doi: 10.4103/lungindia.lungindia_39_19. [Accessed 19 Jun. 2024] Available at:
• Ding L, Luo K, Feng CG, Oehlers SH. Pidotimod increases inflammation in wounded zebrafish embryos. Fish Shellfish Immunol. 2022 Jan;120:429-433. doi: 10.1016/j.fsi.2021.12.013. Epub 2021 Dec 16. [Accessed 22 Jun. 2024] Available at:
• Niu H, Wang R, Jia YT, Cai Y. Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials. Int Immunopharmacol. 2019 Feb;67:35-45. doi: 10.1016/j.intimp.2018.11.043. Epub 2018 Dec 7. [Accessed 25 Jun. 2024] Available at: